Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 166

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Immune Landscape of Colorectal Cancer Tumor Microenvironment from Different Primary Tumor Location

Open access
Zhang, Longhui, Zhao, Yuetao, Dai, Ying, Cheng, Jia-Nan, Gong, Zhihua, Feng, Yi, Sun, Chengdu, Jia, Qingzhu, Zhu, Bo · 2018 · Frontiers in Immunology

Abstract

To define differences in tumor microenvironment immune phenotypes between right and left CRCs and explore their therapeutic implications.Gene expression profiling and clinical characteristics of patients with colorectal cancer were retrieved from The Cancer Genome Atlas (TCGA) data portal. Immune cell infiltration was estimated based on single sample gene set enrichment analysis (ssGSEA).CRCs tissue microarrays containing 90 consecutive cases of surgically-resected samples were used for validation. Expression of CD8A and VEGFA was confirmed by immunohistochemistry (IHC) analysis with tissue microarrays, and overall survival (OS) was analyzed.Expression profiling data demonstrated that CRC immune microenvironment from right side tumor was characterized as increased infiltration of immune cells with enhanced cytotoxic function, based on higher cytotoxic activity scores (CYT) and interferon-γ signatures. Expression of VEGFA, which could be neutralized by bevacizumab, was associated with decreased levels of activated CD8+ T-cells, Th1 cells, and PRF1 expression on the right side, but not on the left side. IHC analysis of tissue microarrays further confirmed an inverse correlation between CD8A and VEGFA expression, and revealed a favorable OS for patients with CD8AHiVEGFALo disease among right-side CRCs. For the left side, higher CD56bright NK cell infiltration and active 4-1BB/IFN-ɑ signaling, which could providing a favorable condition for cetuximab mediated antibody-dependent cell-mediated cytotoxicity (ADCC) effect, was present in a cohort with extended OS.In the tumor microenvironment, features of immune phenotype sidedness were identified, providing an implication for differential responses to bevacizumab/cetuximab treatment. Additionally, a new avenue for innovative experimental design and combinational immunotherapy to treat CRC patients was suggested.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2018.01578

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Cited by

See all 166

Metadata

Authors
Zhang, L., Zhao, Y., Dai, Y., Cheng, J.-N., Gong, Z., Feng, Y., Sun, C., Jia, Q., & Zhu, B.
Venue
Frontiers in Immunology
Published
2018-07-10
Volume
9
Pages
1578-1578
ISSN
1664-3224 (ISSN-L)
OpenAlex
W2866490332
Cited by
166
References
21
FWCI
6.57
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Immune Landscape of Colorectal Cancer Tumor Microenvironment from Different Primary Tumor Location. https://app.cochat.ai/papers/10.3389/fimmu.2018.01578
The paper
Zhang, L., Zhao, Y., Dai, Y., Cheng, J.-N., Gong, Z., Feng, Y., Sun, C., Jia, Q., & Zhu, B. (2018). Immune Landscape of Colorectal Cancer Tumor Microenvironment from Different Primary Tumor Location. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2018.01578

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.